https://doctransparency.com/doctor/tx/houston/maen-abdelrahim-1518227735
Medicare Enrolled

Dr. Maen Abdelrahim, MD

Internal Medicine · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6445 MAIN STREET, OPC24, Houston, TX 77030
7134419948
In practice since 2012 (13 years)
NPI: 1518227735 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abdelrahim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abdelrahim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abdelrahim

Dr. Maen Abdelrahim is an internal medicine in Houston, TX, with 13 years in practice. Based on federal Medicare data, Dr. Abdelrahim performed 278 Medicare services across 132 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abdelrahim received a total of $747,593 from 37 pharmaceutical and/or device companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abdelrahim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ 278 Medicare services$ $747,593 industry payments

Medicare Practice Summary

Medicare Utilization ↗
278
Medicare services
Bottom 26% in TX for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
132
Unique beneficiaries
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)233$129$421
Initial hospital admission, moderate complexity23$102$401
New patient office visit, complex (60-74 min)22$159$600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$747,593
Total received (2018-2024)
Avg $106,799/year across 7 years
Top 0% in TX for internal medicine
37
Companies
548
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$699,836 (93.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,145 (5.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,612 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$355,742
2023
$142,288
2022
$70,355
2021
$106,124
2020
$25,595
2019
$27,951
2018
$19,537

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$249,247
Takeda Pharmaceuticals U.S.A., Inc.
$167,924
AstraZeneca Pharmaceuticals LP
$102,079
PFIZER INC.
$39,383
Astellas Pharma US Inc
$38,871
Incyte Corporation
$30,735
ARRAY BIOPHARMA INC
$25,894
Daiichi Sankyo Inc.
$21,714
Seagen Inc.
$18,958
Eisai Inc.
$8,056
Lexicon Pharmaceuticals, Inc.
$7,966
JAZZ PHARMACEUTICALS INC.
$7,500
Exelixis Inc.
$5,386
AstraZeneca UK Limited
$4,665
Genentech USA, Inc.
$3,348
E.R. Squibb & Sons, L.L.C.
$3,094
TerSera Therapeutics LLC
$2,835
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,220
Astellas Pharma Global Development
$2,188
Helsinn Therapeutics (U.S.), Inc.
$2,175
Ipsen Bioscience Inc
$1,551
Pfizer Inc.
$598
FUJIFILM Healthcare Americas Corporation
$289
Genentech, Inc.
$195
Bayer HealthCare Pharmaceuticals Inc.
$119
EISAI INC.
$117
ABBVIE INC.
$88
Merck Sharp & Dohme LLC
$78
Celgene Corporation
$72
TAIHO ONCOLOGY, INC.
$43
Shionogi Inc
$40
Merck Sharp & Dohme Corporation
$37
Amgen Inc.
$36
Biocompatibles, Inc.
$36
Sirtex Medical Inc
$23
AbbVie Inc.
$19
Tactile Systems Technology Inc
$15
Top 3 companies account for 69.5% of total payments
Associated products mentioned in payments ›
AVYCAZ · Abraxane · Alecensa · BRAFTOVI · CABOMETYX · DIFICID · ENHERTU · Enhertu · FRUZAQLA · Flexitouch Plus · IMFINZI · IMJUDO · JAKAFI · KEYTRUDA · LONSURF · LYNPARZA · Lenvima · MAVYRET · Mulpleta · Nplate · ONIVYDE · Onivyde · PEMAZYRE · SIR-Spheres Microspheres · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TEFLARO · THERASPHERE-BIO · TRUSELTIQ · TUKYSA · Tecentriq · UTASWAKO AFP-L3 · Vyloy · Xermelo · ZANIDATAMAB · uTASWako AFP-L3
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $268,918 per 100 Medicare services performed
Looking for a internal medicine in Houston?
Compare internal medicines in the Houston area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,667
Per 100K population
56.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abdelrahim is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 0%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Abdelrahim experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Abdelrahim performed 233 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abdelrahim receive payments from pharmaceutical companies?
Yes. Dr. Abdelrahim received a total of $747,593 from 37 companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abdelrahim's costs compare to other internal medicines in Houston?
Dr. Abdelrahim's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abdelrahim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →